Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease

Luigi Zecca; Christian Pifl; Stanley Fahn; David Sulzer; Ruggero G. Fariello

doi:10.1038/s41531-020-00149-4

npj Parkinson's Disease (Jan 2021)

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease

Luigi Zecca,
Christian Pifl,
Stanley Fahn,
David Sulzer,
Ruggero G. Fariello

Affiliations

Luigi Zecca: Institute of Biomedical Technologies, National Research Council of Italy, Segrate
Christian Pifl: Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna
Stanley Fahn: Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University and the New York Presbyterian Hospital
David Sulzer: Departments of Psychiatry, Neurology, Pharmacology, Columbia University Medical Center, New York State Psychiatric Institute
Ruggero G. Fariello: PharmaFox Therapeutics AG

DOI: https://doi.org/10.1038/s41531-020-00149-4
Journal volume & issue: Vol. 7, no. 1
pp. 1 – 4

Abstract

Read online

Oleh Hornykiewicz (November 17, 1926–May 26, 2020), by demonstrating the loss of dopamine neurons in Parkinson’s disease, introducing the effort to treat the disorder with L-DOPA, and other innovative research, improved the lives of countless individuals and transformed neurology and medical science. Here we celebrate the life and great achievements of an outstanding scientist.

Published in npj Parkinson's Disease

ISSN: 2373-8057 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: https://www.nature.com/npjparkd/

About the journal